Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 11;82(3):287-296.
doi: 10.1055/a-1555-3444. eCollection 2022 Mar.

Administration of Antenatal Corticosteroids: Current State of Knowledge

Richard Berger  1 , Ioannis Kyvernitakis  2 , Holger Maul  2
Affiliations

Administration of Antenatal Corticosteroids: Current State of Knowledge

Richard Berger et al. Geburtshilfe Frauenheilkd. .

Abstract

The administration of a single course of corticosteroids before week 34 + 0 of gestation in cases with impending preterm birth is now standard procedure in obstetric care and firmly established in the guidelines of different countries. But despite the apparently convincing data, numerous aspects of this intervention have not yet been properly studied. It is still not clear which corticosteroid achieves the best results. There are very few studies on what constitutes an appropriate dose, circadian rhythms, the time frame in which corticosteroids are effective, and the balance between the risks and benefits of repeat administration. As the existing studies have rarely included patients before week 24 + 0 of gestation, we have very little information on the possible benefits of administering corticosteroids before this timepoint. If corticosteroids are administered antenatally after week 34 + 0 of gestation, the short-term benefit may be offset by the long-term adverse effect on psychomotor development. This present study summarizes the current state of knowledge regarding these issues.

Keywords: corticosteroids; dose; preterm birth; timing.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest/Interessenkonflikt The authors declare that they have no conflict of interest.

References

    1. Liggins G C, Howie R N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50:515–525. - PubMed
    1. McGoldrick E, Stewart F, Parker R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;(12):CD004454. - PMC - PubMed
    1. NICE Guideline. Preterm labour and birth 2015Accessed September 26, 2021 at:http://www.nice.org.uk/guidance/ng25
    1. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol. 2017;130:e102–e109. - PubMed
    1. Skoll A, Boutin A, Bujold E. No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes. J Obstet Gynaecol Can. 2018;40:1219–1239. - PubMed